07.07.25 -- The Shift From LAL To Recombinant: What Your Lab Should Expect

On this week’s Business of Biotech, NewYorkBIO CEO Jennifer Hawks Bland discusses New York’s growing life sciences ecosystem, her transition from Capitol Hill to biotech advocacy, and the policy work fueling biotech innovation. Tune in for insights on key programs and funding opportunities for early-stage companies. Brought to you by Ecolab Life Sciences.

AAV has become an increasingly popular vector for gene therapy applications, yet ongoing challenges related to process and analytical development often require significant expertise to navigate.

As Electronic Data Capture (EDC) systems continue to evolve, they streamline workflows, enhance data security, and improve patient outcomes.

As cancer therapies grow more complex and personalized, patient-reported outcomes (PROs) have emerged as a vital component of oncology research and care.

Discover how mobile visits are transforming clinical trials by reducing barriers to participation, enhancing diversity, and bringing studies closer to patients and their communities.

Discover how 4,500 jobs were created across 16 communities and how North Carolina achieved a record-breaking year by securing over $10 billion in life sciences investments.

What does it take to lead in today's evolving pharmaceutical landscape? Insights from Pharma 2025 reveal that empowering teams through trust, experimentation, and a shared purpose is key.

Learn how kindness transformed the trial experience for pediatric participants in a global study. The team at Myrtelle, a patient-centered gene therapy company for neurological diseases, shares more.